Skip to main content

Clene Inc.

CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822791

No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Clene Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CLNN: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders44137−6
Shares7.29M3.90K6.75M−535.7K (−7.3%)
Value$3.10M$1.00K$2.40M−$695.5K (−22.4%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Clene Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CLNN in Q2 2024
InstitutionSharesValue% of portfolio
Jane Street Group, LLC17,584$6.26K0.00%
TownSquare Capital, LLC13,678$4.87K0.00%
FMR LLC2,223$7920.00%

Sold out (9)

Institutions that held Clene Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CLNN in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Condor Capital Management58,046$24.7K
SRS Capital Advisors, Inc.55,250$23.5K
HRT Financial LP33,018$14.0K
XTX Topco Ltd25,047$10.7K
Lincoln National Corp20,350$8.66K
Millennium Management LLC20,263$8.62K
Pallas Capital Advisors LLC17,341$7.38K
Vontobel Holding Ltd.15,000$6.38K
Wells Fargo & Company733$312

Not filed for Q2 2024 yet (1)

Institutions that held Clene Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLNN in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cutler Group LP3,900$1.00K